New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
07:38 EDTSUPNSupernus to receive $30M in non-dilutive royalty deal
Supernus Pharmaceuticals announced the execution of a royalty acquisition agreement with HealthCare Royalty Partners. Per the Agreement, HC Royalty will make a $30M cash payment to Supernus in consideration for acquiring from Supernus certain royalty and milestone rights related to the commercialization of Orenitram Extended-Release Tablets by Supernus' partner United Therapeutics Corporation. Supernus will retain full ownership of the Royalty Rights after a certain threshold has been reached per the terms of the Agreement.
News For SUPN From The Last 14 Days
Check below for free stories on SUPN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SUPN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use